Product Information

TOPIRAMATE 100 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0550 per EA under NDC 82009013705. Its NADAC has been published 149 times since Oct 18, 2023.

FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE 100 MG TABLET

topiramate
$0.0550per EA

Strength

100 mg/1

NDC

82009013705

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078235

FDA Approved

3/27/2009

TE Code

AB

On Market Since

7/24/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 100 MG TABLET has been published 149 times since Oct 18, 2023, and over the history we have for it it has declined 12.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0550 per EA
All-time high$0.0691 (Apr 10, 2024)
All-time low$0.0486 (Nov 20, 2024)
52-week high$0.0645
52-week low$0.0550
Median price$0.0620
Average price$0.0609
Largest weekly change+33.1% (Aug 21, 2024)
Weeks tracked149
Tracking sinceOct 18, 2023

Price History

1W

-1.0%

1M

-1.0%

3M

-7.5%

6M

-6.7%

1Y

-14.7%

3Y

N/A

5Y

N/A

All

-12.5%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 100 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0550 per EA (NDC 82009013705), effective Aug 19, 2026.

How has the price of TOPIRAMATE 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 100 MG TABLET has declined 12.5%. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 100 MG TABLET?

Since Oct 18, 2023, the NADAC for TOPIRAMATE 100 MG TABLET has ranged from a low of $0.0486 (Nov 20, 2024) to a high of $0.0691 (Apr 10, 2024), with a median of $0.0620 per EA.

Are there cheaper alternatives to TOPIRAMATE 100 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE 100 MG TABLET?

TOPIRAMATE 100 MG TABLET (NDC 82009013705) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.